http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-20210085309-A

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_4820e6ded4d368fa1fde368d6f96f753
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-5377
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-1658
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-1617
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-1635
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-1652
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-5377
filingDate 2019-12-30-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1fb9013606b3df469b36c4ebdd1decdd
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_121f618f387337a6ac7f406cc3bd188b
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_dac8d43a871f9d4775e54934fd8e5426
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6337652497a7f26e6c655b99f56c2fc3
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_22aa634a6921232446c03feb4c21eede
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_cd7fab2b01d2414b5a0d523a1cdf1f13
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a5f4a1787238fde1f6d2ba887a5d039a
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_03a085c2108884192cf5e21bae153aa1
publicationDate 2021-07-08-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber KR-20210085309-A
titleOfInvention Rivaroxaban-containing solid dispersion and method for preparation the same
abstract The present invention relates to a solid dispersion for oral administration with improved bioavailability, based on 100 parts by weight of rivaroxaban, 10 to 200 parts by weight of sodium lauryl sulfate; and 10 to 50 parts by weight of a water-soluble polymer; and a rivaroxaban-containing solid dispersion comprising the same, a pharmaceutical composition comprising the same, and a method for preparing them, for oral administration with improved water solubility and dissolution rate and improved bioavailability A solid dispersion is provided.
priorityDate 2019-12-30-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-20160026836-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-101535586-B1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-20140082656-A
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID451905405
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID51064083
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID451369657
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID87984350
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID415722021
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID60606
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID423352616
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID36573
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID57503849
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419475894
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID453335048
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID14049689
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3423265
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419512635
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID962
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419582371
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID444041
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419534242
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID9875401
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID448380735
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID426208976
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID517347

Total number of triples: 48.